Skip to main content

ImmunoPrecise Antibodies Ltd. (IPA)

NASDAQ: IPA · IEX Real-Time Price · USD
1.55
-0.08 (-5.20%)
Nov 30, 2023, 12:26 PM EST - Market open

ImmunoPrecise Antibodies Revenue

ImmunoPrecise Antibodies had revenue of $16.41M in the twelve months ending July 31, 2023, with 9.61% growth year-over-year. Revenue in the quarter ending July 31, 2023 was $4.31M with 19.47% year-over-year growth. In the fiscal year ending April 30, 2023, ImmunoPrecise Antibodies had annual revenue of $15.42M with 0.35% growth.

Revenue (ttm)
$16.41M
Revenue Growth
+9.61%
P/S Ratio
2.58
Revenue / Employee
$160,903
Employees
102
Market Cap
37.58M USD

Revenue Chart

* The company reports in CAD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Apr 30, 202315.42M53.39K
0.35%
Apr 30, 202215.37M805.65K
5.53%
Apr 30, 202114.56M4.59M
46.06%
Apr 30, 20209.97M1.85M
22.73%
Apr 30, 20198.12M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IPA News

More News